ID   FADS2_HUMAN             Reviewed;         444 AA.
AC   O95864; A8K2M6; B7Z634; Q6MZQ7; Q96H07; Q96SV8; Q9H3G3; Q9Y3X4;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   15-MAR-2017, entry version 136.
DE   RecName: Full=Fatty acid desaturase 2;
DE            EC=1.14.19.3 {ECO:0000269|PubMed:12713571, ECO:0000269|PubMed:9867867};
DE   AltName: Full=Acyl-CoA 6-desaturase;
DE   AltName: Full=Delta(6) fatty acid desaturase;
DE            Short=D6D;
DE            Short=Delta(6) desaturase;
DE            Short=Delta-6 desaturase;
GN   Name=FADS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=9867867; DOI=10.1074/jbc.274.1.471;
RA   Cho H.P., Nakamura M.T., Clarke S.D.;
RT   "Cloning, expression, and nutritional regulation of the mammalian
RT   Delta-6 desaturase.";
RL   J. Biol. Chem. 274:471-477(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=10860662; DOI=10.1006/geno.2000.6196;
RA   Marquardt A., Stoehr H., White K., Weber B.H.;
RT   "cDNA cloning, genomic structure, and chromosomal localization of
RT   three members of the human fatty acid desaturase family.";
RL   Genomics 66:175-183(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Mesothelium;
RA   Zhang J.S.S., Reddel R.R.;
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 277-444 (ISOFORMS 1/2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 134-444 (ISOFORMS 1/2).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [10]
RP   INDUCTION.
RX   PubMed=12147235; DOI=10.1016/S0006-291X(02)00851-3;
RA   Nara T.Y., He W.S., Tang C., Clarke S.D., Nakamura M.T.;
RT   "The E-box like sterol regulatory element mediates the suppression of
RT   human Delta-6 desaturase gene by highly unsaturated fatty acids.";
RL   Biochem. Biophys. Res. Commun. 296:111-117(2002).
RN   [11]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12713571; DOI=10.1046/j.1523-1747.2003.12123.x;
RA   Ge L., Gordon J.S., Hsuan C., Stenn K., Prouty S.M.;
RT   "Identification of the delta-6 desaturase of human sebaceous glands:
RT   expression and enzyme activity.";
RL   J. Invest. Dermatol. 120:707-714(2003).
RN   [12]
RP   ERRATUM.
RA   Ge L., Gordon J.S., Hsuan C., Stenn K., Prouty S.M.;
RL   J. Invest. Dermatol. 121:434-434(2003).
RN   [13]
RP   INDUCTION.
RX   PubMed=12562861; DOI=10.1194/jlr.M200195-JLR200;
RA   Tang C., Cho H.P., Nakamura M.T., Clarke S.D.;
RT   "Regulation of human delta-6 desaturase gene transcription:
RT   identification of a functional direct repeat-1 element.";
RL   J. Lipid Res. 44:686-695(2003).
RN   [14]
RP   TISSUE SPECIFICITY.
RX   PubMed=12851727;
RA   Lane J., Mansel R.E., Jiang W.G.;
RT   "Expression of human delta-6-desaturase is associated with
RT   aggressiveness of human breast cancer.";
RL   Int. J. Mol. Med. 12:253-257(2003).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Component of a lipid metabolic pathway that catalyzes
CC       biosynthesis of highly unsaturated fatty acids (HUFA) from
CC       precursor essential polyunsaturated fatty acids (PUFA) linoleic
CC       acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3).
CC       Catalyzes the first and rate limiting step in this pathway which
CC       is the desaturation of LA (18:2n-6) and ALA (18:3n-3) into gamma-
CC       linoleic acid (GLA) (18:3n-6) and stearidonic acid (18:4n-3)
CC       respectively and other desaturation steps. Highly unsaturated
CC       fatty acids (HUFA) play pivotal roles in many biological
CC       functions. It catalizes as well the introduction of a cis double
CC       bond in palmitate to produce the mono-unsaturated fatty acid
CC       sapienate, the most abundant fatty acid in sebum.
CC       {ECO:0000269|PubMed:12713571, ECO:0000269|PubMed:9867867}.
CC   -!- CATALYTIC ACTIVITY: Linoleoyl-CoA + 2 ferrocytochrome b5 + O(2) +
CC       2 H(+) = gamma-linolenoyl-CoA + 2 ferricytochrome b5 + 2 H(2)O.
CC       {ECO:0000269|PubMed:12713571, ECO:0000269|PubMed:9867867}.
CC   -!- CATALYTIC ACTIVITY: Alpha-linolenoyl-CoA + 2 ferrocytochrome b5 +
CC       O(2) + 2 H(+) = stearidonoyl-CoA + 2 ferricytochrome b5 + 2 H(2)O.
CC       {ECO:0000269|PubMed:12713571, ECO:0000269|PubMed:9867867}.
CC   -!- PATHWAY: Lipid metabolism; polyunsaturated fatty acid
CC       biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O95864-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95864-2; Sequence=VSP_028568;
CC       Name=3;
CC         IsoId=O95864-3; Sequence=VSP_028569;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=O95864-4; Sequence=VSP_054809;
CC   -!- TISSUE SPECIFICITY: Expressed in a wide array of tissues, highest
CC       expression is found in liver followed by brain, lung, heart, and
CC       retina. A lower level is found in breast tumor when compared with
CC       normal tissues; lowest levels were found in patients with poor
CC       prognostic index. {ECO:0000269|PubMed:10860662,
CC       ECO:0000269|PubMed:12851727, ECO:0000269|PubMed:9867867}.
CC   -!- DEVELOPMENTAL STAGE: Found in fetal heart.
CC   -!- INDUCTION: Repressed by dietary highly unsaturated fatty acids.
CC       {ECO:0000269|PubMed:12147235, ECO:0000269|PubMed:12562861}.
CC   -!- DOMAIN: The histidine box domains may contain the active site
CC       and/or be involved in metal ion binding.
CC   -!- SIMILARITY: Belongs to the fatty acid desaturase type 1 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF126799; AAD20018.1; -; mRNA.
DR   EMBL; AF084559; AAG23121.1; -; mRNA.
DR   EMBL; AF108658; AAG43192.1; -; mRNA.
DR   EMBL; AK027513; BAB55167.1; -; mRNA.
DR   EMBL; AK290291; BAF82980.1; -; mRNA.
DR   EMBL; AK299762; BAH13120.1; -; mRNA.
DR   EMBL; AK074939; BAC11305.1; -; mRNA.
DR   EMBL; AP002380; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW73975.1; -; Genomic_DNA.
DR   EMBL; BC009011; AAH09011.1; -; mRNA.
DR   EMBL; AL050118; CAB43280.1; -; mRNA.
DR   EMBL; BX640945; CAE45971.1; -; mRNA.
DR   CCDS; CCDS60807.1; -. [O95864-2]
DR   CCDS; CCDS60808.1; -. [O95864-4]
DR   CCDS; CCDS8012.1; -. [O95864-1]
DR   PIR; T13155; T13155.
DR   RefSeq; NP_001268430.1; NM_001281501.1. [O95864-2]
DR   RefSeq; NP_001268431.1; NM_001281502.1. [O95864-4]
DR   RefSeq; NP_004256.1; NM_004265.3. [O95864-1]
DR   UniGene; Hs.502745; -.
DR   ProteinModelPortal; O95864; -.
DR   SMR; O95864; -.
DR   BioGrid; 114810; 8.
DR   IntAct; O95864; 8.
DR   MINT; MINT-2866355; -.
DR   STRING; 9606.ENSP00000278840; -.
DR   BindingDB; O95864; -.
DR   ChEMBL; CHEMBL6097; -.
DR   DrugBank; DB00132; Alpha-Linolenic Acid.
DR   SwissLipids; SLP:000000275; -.
DR   iPTMnet; O95864; -.
DR   PhosphoSitePlus; O95864; -.
DR   SwissPalm; O95864; -.
DR   EPD; O95864; -.
DR   MaxQB; O95864; -.
DR   PaxDb; O95864; -.
DR   PeptideAtlas; O95864; -.
DR   PRIDE; O95864; -.
DR   Ensembl; ENST00000257261; ENSP00000257261; ENSG00000134824. [O95864-2]
DR   Ensembl; ENST00000278840; ENSP00000278840; ENSG00000134824. [O95864-1]
DR   Ensembl; ENST00000521849; ENSP00000431091; ENSG00000134824. [O95864-3]
DR   Ensembl; ENST00000522056; ENSP00000429500; ENSG00000134824. [O95864-4]
DR   GeneID; 9415; -.
DR   KEGG; hsa:9415; -.
DR   UCSC; uc001nsj.4; human. [O95864-1]
DR   CTD; 9415; -.
DR   DisGeNET; 9415; -.
DR   GeneCards; FADS2; -.
DR   HGNC; HGNC:3575; FADS2.
DR   HPA; HPA006741; -.
DR   MIM; 606149; gene.
DR   neXtProt; NX_O95864; -.
DR   OpenTargets; ENSG00000134824; -.
DR   PharmGKB; PA27974; -.
DR   eggNOG; KOG4232; Eukaryota.
DR   eggNOG; ENOG410XVSZ; LUCA.
DR   GeneTree; ENSGT00510000046574; -.
DR   HOGENOM; HOG000012997; -.
DR   HOVERGEN; HBG002839; -.
DR   InParanoid; O95864; -.
DR   KO; K10226; -.
DR   OMA; AWFTIFY; -.
DR   OrthoDB; EOG091G0E0W; -.
DR   PhylomeDB; O95864; -.
DR   TreeFam; TF313604; -.
DR   BioCyc; MetaCyc:HS05918-MONOMER; -.
DR   BRENDA; 1.14.19.3; 2681.
DR   Reactome; R-HSA-2046105; Linoleic acid (LA) metabolism.
DR   Reactome; R-HSA-2046106; alpha-linolenic acid (ALA) metabolism.
DR   UniPathway; UPA00658; -.
DR   ChiTaRS; FADS2; human.
DR   GeneWiki; FADS2; -.
DR   GenomeRNAi; 9415; -.
DR   PRO; PR:O95864; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000134824; -.
DR   CleanEx; HS_FADS2; -.
DR   ExpressionAtlas; O95864; baseline and differential.
DR   Genevisible; O95864; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0016213; F:linoleoyl-CoA desaturase activity; TAS:Reactome.
DR   GO; GO:0004768; F:stearoyl-CoA 9-desaturase activity; IEA:Ensembl.
DR   GO; GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome.
DR   GO; GO:0043651; P:linoleic acid metabolic process; TAS:Reactome.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; TAS:ProtInc.
DR   Gene3D; 3.10.120.10; -; 1.
DR   InterPro; IPR001199; Cyt_B5-like_heme/steroid-bd.
DR   InterPro; IPR005804; FA_desaturase_dom.
DR   InterPro; IPR012171; Fatty_acid_desaturase.
DR   Pfam; PF00173; Cyt-b5; 1.
DR   Pfam; PF00487; FA_desaturase; 1.
DR   PIRSF; PIRSF015921; FA_sphinglp_des; 1.
DR   SMART; SM01117; Cyt-b5; 1.
DR   SUPFAM; SSF55856; SSF55856; 1.
DR   PROSITE; PS50255; CYTOCHROME_B5_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Electron transport;
KW   Endoplasmic reticulum; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Oxidoreductase;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    444       Fatty acid desaturase 2.
FT                                /FTId=PRO_0000307101.
FT   TOPO_DOM      1    131       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    132    152       Helical. {ECO:0000255}.
FT   TOPO_DOM    153    157       Lumenal. {ECO:0000255}.
FT   TRANSMEM    158    178       Helical. {ECO:0000255}.
FT   TOPO_DOM    179    264       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    265    285       Helical. {ECO:0000255}.
FT   TOPO_DOM    286    305       Lumenal. {ECO:0000255}.
FT   TRANSMEM    306    326       Helical. {ECO:0000255}.
FT   TOPO_DOM    327    444       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       18     95       Cytochrome b5 heme-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00279}.
FT   MOTIF       180    184       Histidine box-1.
FT   MOTIF       217    221       Histidine box-2.
FT   MOTIF       382    386       Histidine box-3.
FT   VAR_SEQ       1     69       MGKGGNQGEGAAEREVSVPTFSWEEIQKHNLRTDRWLVIDR
FT                                KVYNITKWSIQHPGGQRVIGHYAGEDAT -> MHGREAGPF
FT                                VCVCVLLASIPTPQTPLLQASLPPFHPASAGHPITGQQ
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_028568.
FT   VAR_SEQ       1     69       MGKGGNQGEGAAEREVSVPTFSWEEIQKHNLRTDRWLVIDR
FT                                KVYNITKWSIQHPGGQRVIGHYAGEDAT -> MTREPPGCR
FT                                RVNSLMLYTLRSITSHRSSHPERWATSSQ (in isoform
FT                                4). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054809.
FT   VAR_SEQ     386    444       HLFPTMPRHNLHKIAPLVKSLCAKHGIEYQEKPLLRALLDI
FT                                IRSLKKSGKLWLDAYLHK -> Q (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_028569.
FT   CONFLICT    134    137       LLLL -> RTRG (in Ref. 9; CAB43280).
FT                                {ECO:0000305}.
FT   CONFLICT    380    381       NF -> SL (in Ref. 4; BAB55167).
FT                                {ECO:0000305}.
FT   CONFLICT    429    431       SLK -> DLM (in Ref. 9; CAB43280).
FT                                {ECO:0000305}.
SQ   SEQUENCE   444 AA;  52259 MW;  F65CE58076961A7A CRC64;
     MGKGGNQGEG AAEREVSVPT FSWEEIQKHN LRTDRWLVID RKVYNITKWS IQHPGGQRVI
     GHYAGEDATD AFRAFHPDLE FVGKFLKPLL IGELAPEEPS QDHGKNSKIT EDFRALRKTA
     EDMNLFKTNH VFFLLLLAHI IALESIAWFT VFYFGNGWIP TLITAFVLAT SQAQAGWLQH
     DYGHLSVYRK PKWNHLVHKF VIGHLKGASA NWWNHRHFQH HAKPNIFHKD PDVNMLHVFV
     LGEWQPIEYG KKKLKYLPYN HQHEYFFLIG PPLLIPMYFQ YQIIMTMIVH KNWVDLAWAV
     SYYIRFFITY IPFYGILGAL LFLNFIRFLE SHWFVWVTQM NHIVMEIDQE AYRDWFSSQL
     TATCNVEQSF FNDWFSGHLN FQIEHHLFPT MPRHNLHKIA PLVKSLCAKH GIEYQEKPLL
     RALLDIIRSL KKSGKLWLDA YLHK
//
